AR033151A1 - Agente para el tratamiento oftalmico topico de las enfermedades inflamatorias oculares - Google Patents
Agente para el tratamiento oftalmico topico de las enfermedades inflamatorias ocularesInfo
- Publication number
- AR033151A1 AR033151A1 ARP020101334A ARP020101334A AR033151A1 AR 033151 A1 AR033151 A1 AR 033151A1 AR P020101334 A ARP020101334 A AR P020101334A AR P020101334 A ARP020101334 A AR P020101334A AR 033151 A1 AR033151 A1 AR 033151A1
- Authority
- AR
- Argentina
- Prior art keywords
- agent
- inflammatory
- present agent
- ophthalmic treatment
- eye
- Prior art date
Links
- 230000000699 topical effect Effects 0.000 title abstract 3
- 208000027866 inflammatory disease Diseases 0.000 title 1
- 239000003795 chemical substances by application Substances 0.000 abstract 6
- 208000030533 eye disease Diseases 0.000 abstract 3
- 230000002757 inflammatory effect Effects 0.000 abstract 3
- 229940121363 anti-inflammatory agent Drugs 0.000 abstract 2
- 239000002260 anti-inflammatory agent Substances 0.000 abstract 2
- 230000000694 effects Effects 0.000 abstract 2
- 150000003431 steroids Chemical class 0.000 abstract 2
- 238000011200 topical administration Methods 0.000 abstract 2
- 108010036941 Cyclosporins Proteins 0.000 abstract 1
- 206010030113 Oedema Diseases 0.000 abstract 1
- 208000003251 Pruritus Diseases 0.000 abstract 1
- 208000025865 Ulcer Diseases 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 230000003110 anti-inflammatory effect Effects 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 229930182912 cyclosporin Natural products 0.000 abstract 1
- 230000007803 itching Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 208000024891 symptom Diseases 0.000 abstract 1
- 231100000397 ulcer Toxicity 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US28316901P | 2001-04-12 | 2001-04-12 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR033151A1 true AR033151A1 (es) | 2003-12-03 |
Family
ID=23084835
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP020101334A AR033151A1 (es) | 2001-04-12 | 2002-04-11 | Agente para el tratamiento oftalmico topico de las enfermedades inflamatorias oculares |
Country Status (12)
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ530845A (en) * | 2001-07-06 | 2006-03-31 | Sucampo Ag | Composition for topical administration |
| US20050043286A1 (en) * | 2001-11-19 | 2005-02-24 | Mario Fsadni | Use of an ascomycin for the treatment of blepharitis |
| EP1536793A1 (en) * | 2002-08-09 | 2005-06-08 | Sucampo Pharmaceuticals, Inc. | Pharmaceutical compositions comprising fk506 derivatives and the ir use for the treatment of allergic diseases |
| US7354574B2 (en) | 2002-11-07 | 2008-04-08 | Advanced Ocular Systems Limited | Treatment of ocular disease |
| US20040198763A1 (en) * | 2003-01-16 | 2004-10-07 | Sucampo Ag | Method of treating dry eye with a macrolide compound |
| US7220422B2 (en) * | 2003-05-20 | 2007-05-22 | Allergan, Inc. | Methods and compositions for treating eye disorders |
| US7083802B2 (en) | 2003-07-31 | 2006-08-01 | Advanced Ocular Systems Limited | Treatment of ocular disease |
| US7087237B2 (en) | 2003-09-19 | 2006-08-08 | Advanced Ocular Systems Limited | Ocular solutions |
| US7083803B2 (en) | 2003-09-19 | 2006-08-01 | Advanced Ocular Systems Limited | Ocular solutions |
| BRPI0608152A2 (pt) | 2005-02-09 | 2009-11-10 | Macusight Inc | formulações para tratamento ocular |
| US8663639B2 (en) | 2005-02-09 | 2014-03-04 | Santen Pharmaceutical Co., Ltd. | Formulations for treating ocular diseases and conditions |
| WO2007092620A2 (en) | 2006-02-09 | 2007-08-16 | Macusight, Inc. | Stable formulations, and methods of their preparation and use |
| CA2645488C (en) * | 2006-03-23 | 2014-09-02 | Macusight, Inc. | Formulations comprising rapamycin and methods using same for vascular permeability-related diseases or conditions |
| US8536190B2 (en) * | 2007-01-30 | 2013-09-17 | Allergan, Inc. | Treating unwanted ocular conditions using an ascomycin macrolactam |
| US20170198026A1 (en) * | 2014-06-06 | 2017-07-13 | The Schepens Eye Research Institute, Inc. | Compositions And Methods For Treating Tumors And Immune Based Inflammatory Diseases |
| EP3721868B1 (en) * | 2015-01-26 | 2022-06-01 | Bausch & Lomb Incorporated | Ophthalmic suspension composition |
| KR101710412B1 (ko) | 2015-09-15 | 2017-02-27 | 인제대학교 산학협력단 | Ycg063을 유효성분으로 함유하는 염증성 안구질환 예방 또는 치료용 약학조성물 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4894366A (en) * | 1984-12-03 | 1990-01-16 | Fujisawa Pharmaceutical Company, Ltd. | Tricyclo compounds, a process for their production and a pharmaceutical composition containing the same |
| DK0406791T3 (da) * | 1989-07-05 | 1995-03-27 | Fujisawa Pharmaceutical Co | Vandigt flydende præparat til ekstern anvendelse |
| DE69021833T2 (de) * | 1989-11-09 | 1996-03-21 | Sandoz Ag | Heteroatome enthaltende tricyclische Verbindungen. |
| IE65341B1 (en) * | 1990-11-08 | 1995-10-18 | Fujisawa Pharmaceutical Co | Suspensions containing tricyclic compounds |
| US5514686A (en) * | 1991-04-26 | 1996-05-07 | Fujisawa Pharmaceutical Co., Ltd. | Use of macrolide compounds for eye diseases |
| AR004480A1 (es) * | 1995-04-06 | 1998-12-16 | Amico Derin C D | Compuestos de ascomicina que poseen actividad antiinflamatoria, pro cedimiento para prepararlos, uso de dichos compuestos para preparar agentesfarmaceuticos y composiciones farmaceuticas que los incluyen |
-
2002
- 2002-04-11 AR ARP020101334A patent/AR033151A1/es not_active Application Discontinuation
- 2002-04-12 MX MXPA03009273A patent/MXPA03009273A/es unknown
- 2002-04-12 CN CNA028082001A patent/CN1503671A/zh active Pending
- 2002-04-12 EP EP02717124A patent/EP1379247A1/en not_active Withdrawn
- 2002-04-12 JP JP2002582932A patent/JP2004529928A/ja not_active Abandoned
- 2002-04-12 BR BR0208939-4A patent/BR0208939A/pt not_active IP Right Cessation
- 2002-04-12 US US10/120,515 patent/US20020187998A1/en not_active Abandoned
- 2002-04-12 WO PCT/JP2002/003664 patent/WO2002085359A1/en not_active Application Discontinuation
- 2002-04-12 NZ NZ529255A patent/NZ529255A/en unknown
- 2002-04-12 KR KR10-2003-7013323A patent/KR20040007494A/ko not_active Application Discontinuation
- 2002-04-12 CA CA002445508A patent/CA2445508A1/en not_active Abandoned
-
2003
- 2003-10-10 NO NO20034560A patent/NO20034560L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CA2445508A1 (en) | 2002-10-31 |
| NO20034560L (no) | 2003-12-09 |
| BR0208939A (pt) | 2004-04-20 |
| NZ529255A (en) | 2006-09-29 |
| EP1379247A1 (en) | 2004-01-14 |
| MXPA03009273A (es) | 2004-02-12 |
| WO2002085359A1 (en) | 2002-10-31 |
| US20020187998A1 (en) | 2002-12-12 |
| KR20040007494A (ko) | 2004-01-24 |
| CN1503671A (zh) | 2004-06-09 |
| JP2004529928A (ja) | 2004-09-30 |
| NO20034560D0 (no) | 2003-10-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR033151A1 (es) | Agente para el tratamiento oftalmico topico de las enfermedades inflamatorias oculares | |
| ES2393927T5 (es) | Composiciones tópicas | |
| US20070231353A1 (en) | Compositons and methods for maintaining eyelid hygiene | |
| ATE355374T1 (de) | Therapeutische agentien und methoden ihrer verwendung zur behandlung von amyloidogenen erkrankungen | |
| EA200602130A1 (ru) | Замещенные арилацилтиомочевины и родственные соединения; ингибиторы репликации вирусов | |
| CA2502437A1 (en) | Method and composition containing latanoprost for treating ocular hypertension and glaucoma | |
| AR032556A1 (es) | Medicamento de accion inmediata para el tratamiento de la disfuncion sexual | |
| NO20052546L (no) | Substituert arylthiourea og relaterte forbindelser; inhibitorer av viral reproduksjon. | |
| ECSP034815A (es) | "composiciones de timolol y de lipido hipotensivas y los metodos para utilizarlas" | |
| BR0312232A (pt) | Inibidores de caspases e seus usos | |
| PA8622001A1 (es) | Derivados de sulfonamida para el tratamiento de enfermedades | |
| AR044337A1 (es) | Procedimiento para potenciar la cognicion usando ziprasidona | |
| CR6963A (es) | Formas de sal de amida de acido 3.(4-bromo-2,6-difluoro-benciloxi)-5-(3-(4-piprolidin-1-ilbutil)ureido)isotiazol-4-carboxilico y metodo de produccion | |
| ES2341789T3 (es) | Composiciones oftalmicas y metodos de uso de las mismas. | |
| RU2008102249A (ru) | Профилактический или терапевтичесский агент для корнеального /конъюнктивального заболевания | |
| DK0868909T3 (da) | Opthalmisk bæreropløsning | |
| BR9914419A (pt) | Terapia para melhoria da percepção | |
| PA8542901A1 (es) | Uso de (z)-2-ciano-3-hidroxi-but-2-acido enoico-(4-trifluorometilfenil)-amida para tratar la esclerosis multiple | |
| JP2004529928A5 (US20020187998A1-20021212-C00005.png) | ||
| ES2215493T1 (es) | Agente farmacologico que comprende acido picolinico, acido fusarico y sus derivados. | |
| MX2023004537A (es) | Compuestos y metodos para el tratamiento de trastornos oculares. | |
| AR034866A1 (es) | Comprimido que comprende cetirizina y pseudoefedrina | |
| ES2129448T3 (es) | Uso de 2-(2-nitro-4-trifluorometilbenzoil)-1,3-ciclohexanodiona en el tratamiento de tirosinemia y composiciones farmaceuticas. | |
| AR036009A1 (es) | Composicion farmaceutica para el tratamiento o prevencion del dolor visceral y los trastornos gastrointestinales que comprenden un compuesto aminoácido biciclico y uso de este ultimo para fabricar dicha composicion farmaceutica | |
| PE20211978A1 (es) | Compuesto heterociclo pentaciclico |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |